Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Update

by · The Cerbat Gem

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL – Get Free Report) saw a large decrease in short interest in the month of December. As of December 15th, there was short interest totaling 4,639 shares, a decrease of 45.6% from the November 30th total of 8,520 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 42,734 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily volume of 42,734 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the company’s shares are short sold.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Adlai Nortye in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Reduce”.

Get Our Latest Research Report on Adlai Nortye

Adlai Nortye Price Performance

NASDAQ:ANL opened at $1.64 on Friday. Adlai Nortye has a 1 year low of $0.88 and a 1 year high of $2.99. The stock has a 50-day moving average price of $1.46 and a two-hundred day moving average price of $1.57.

Adlai Nortye Company Profile

(Get Free Report)

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.

Featured Stories